An analysis of retinal safety when using a laser based low-level red light therapy device for myopia

This study concludes that the Eyerising Myopia Management Device (EMMD) for low-level red light therapy is safe for retinal use, as its exposure parameters remain well below established thermal and photochemical injury thresholds with substantial safety margins confirmed by laboratory measurements, modeling, and human volunteer data.

The Gist

The Big Picture: Is the "Red Light" Eye Treatment Safe?

Imagine a new kind of "gym" for your eyes. Doctors have been using a device called the Eyerising Myopia Management Device (EMMD) to help slow down nearsightedness (myopia) in children. It works by shining a very gentle, low-level red laser light into the eyes for a few minutes a day.

However, because it involves lasers, parents and doctors have been worried: "Is staring at a laser beam safe for a child's retina? Could it burn or damage their eyes over time?"

This paper is a safety report. Two experts, Karl Schulmeister and John Marshall, put the device under a microscope to answer that question. They didn't just guess; they measured the light, ran computer simulations, and compared the results to what we know about eye injuries.

The Investigation: How They Checked the Safety

The authors treated the device like a suspect in a courtroom and put it through three different "tests" to see if it was guilty of being dangerous.

1. The "Flashlight" Test (Measuring the Light)

First, they went into a lab and measured exactly what the device was doing.

• The Setup: They measured the color (wavelength) and the strength (power) of the red light.
• The Finding: The light is a deep red color (654–655 nm). The power is about 1 milliwatt.
• The Analogy: Think of a standard laser pointer you might use for a presentation. Those are usually Class 2 (under 1 mW) or Class 3R (up to 5 mW). This device is right on the border, just barely stepping into the "Class 3R" zone. It's stronger than a tiny flashlight but much weaker than a laser cutter or a high-powered industrial laser.

2. The "Sunburn" vs. "Heat" Test (Thermal and Photochemical Safety)

The authors looked at two ways light can hurt the eye, using two different metaphors:

• The "Heat" Risk (Thermal Injury):
  Imagine holding a magnifying glass over a leaf on a sunny day. If you focus the sun too hard, the leaf burns. This is thermal damage.

  • The Paper's Claim: The device is so weak that even if a child stared at it without blinking (which the device prevents anyway), the heat generated would be like a gentle warm breeze, not a fire. Their computer models showed that the light would need to be 2.5 times stronger than the device actually is to even start heating the retina enough to cause damage.

• The "Sunburn" Risk (Photochemical Injury):
  Imagine getting a sunburn on your skin. This happens because UV light triggers a chemical reaction. In the eye, blue light is usually the culprit for this "sunburn" (called the blue-light hazard).

  • The Paper's Claim: Red light is very different from blue light. It doesn't have enough energy to trigger that dangerous chemical reaction easily. The authors calculated that the device's light is 38 times weaker than the limit where a "sunburn" would theoretically start to happen. Even if you added up the light from two treatments a day, the "safety margin" is still huge.

3. The "Human Volunteer" Test (Real-World Proof)

Sometimes, computer models aren't enough. The authors looked at a past study where human volunteers intentionally stared into laser beams to see what happened.

• The Experiment: In a previous study, people stared into lasers that were 5 times stronger (5 mW) than the Eyerising device. They stared for up to 15 minutes.
• The Result: The volunteers saw a pink afterimage (like when you look at a bright light and close your eyes), but their vision returned to normal in minutes. Weeks later, doctors looked at their eyes with microscopes and found zero damage.
• The Analogy: If you can stand in a heavy rainstorm (5 mW laser) for 15 minutes and not get wet (no eye damage), you will definitely stay dry in a light drizzle (1 mW laser) for just 6 minutes.

The "Pupil" Factor: Why the Device is Safer Than It Looks

The authors used a "worst-case scenario" for their math: they assumed the child's pupil was wide open (7 mm), like a dark cave, letting all the light in.

• Reality Check: In real life, when you look at something bright, your pupil shrinks (like a camera aperture closing down) to protect the eye.
• The Result: Because the light is bright enough to make the pupil shrink, the actual amount of light entering the eye is likely much less than the "worst-case" math suggested. This makes the safety margin even bigger—roughly 8 times safer than the worst-case calculation.

The Verdict

The paper concludes that the Eyerising device is safe when used exactly as the manufacturer designed it (3 minutes, twice a day, 5 days a week).

• The Safety Net: The device operates well below the limits where scientists know retinal damage occurs.
• The Caveat: The authors note that these safety rules were originally written for accidental laser exposure (like someone pointing a laser at your eye by mistake), not for medical treatment. However, even with the strictest safety rules, the device passes with flying colors.
• One Small Warning: Just like some people are allergic to peanuts, some people might be extra sensitive to light if they are taking certain medications. For those specific individuals, extra caution is needed.

In short: The paper says, "We measured the light, ran the numbers, and checked the history. The red light used for this eye treatment is gentle enough that it won't burn or chemically damage the eye, even with daily use."

Technical Summary

Technical Summary: An Analysis of Retinal Safety for the Eyerising Myopia Management Device (EMMD)

Problem Statement
The prevalence of myopia, particularly in pediatric populations, has led to the development of therapeutic interventions, including repeated low-level red-light (RLRL) therapy. The Eyerising Myopia Management Device (EMMD) is a laser-based system designed to slow myopia progression. While clinical efficacy has been reported, concerns regarding retinal safety have emerged due to the use of laser radiation. Current international safety standards (e.g., IEC 60825-1) were designed for accidental exposure protection, not therapeutic applications, and no specific standards currently exist for RLRL therapy devices. This paper addresses the need for a rigorous safety assessment of the EMMD by analyzing its exposure parameters against established thermal and photochemical injury thresholds.

Methodology
The study employed a multi-faceted approach combining direct measurement, computational modeling, and empirical data comparison:

• Device Characterization: Two EMMD units were tested in an accredited laboratory (Seibersdorf Labor GmbH). Parameters measured included wavelength, intraocular power, corneal irradiance, and retinal image characteristics. Measurements were taken under worst-case conditions, utilizing a 7 mm aperture (representing maximum pupil dilation in children) and simulating various accommodative states to determine the smallest retinal image size.
• Safety Standard Comparison: Measured emission levels were compared against Maximum Permissible Exposure (MPE) limits defined in IEC 60825-1:2014 and ANSI Z80.36-2021.
• Thermal Hazard Modeling: A validated computer model was used to predict retinal thermal injury thresholds. These predictions were benchmarked against non-human primate (NHP) experimental data for red and green wavelengths, assuming a stationary retina (worst-case scenario without eye movements).
• Photochemical Additivity Analysis: The study evaluated the cumulative risk of repeated daily exposures using photochemical additivity principles and repair kinetics (based on Griess & Blankenstein data).
• Human Volunteer Data Contextualization: The EMMD exposure parameters were compared against a published human volunteer study (Robertson et al., 2000) where participants were intentionally exposed to higher-power laser pointers (up to 5.1 mW) for extended durations.

Key Results

• Emission Parameters: The EMMD emits red laser radiation at 654–655 nm. The maximum intraocular power through a 7 mm pupil was measured at approximately 1 mW (ranging 0.93–1.03 mW), placing the device marginally above the Class 2 limit and within the Class 3R category.
• Thermal Safety: Thermal injury modeling indicated that the retinal damage threshold is significantly higher than the device's exposure level. Even under worst-case assumptions (minimal retinal image size of ~25 µm and a stationary retina), the predicted injury threshold for a 200-second exposure is 2.5 mW, which is 2.5 times higher than the EMMD's 1 mW output.
• Photochemical Safety: The corneal irradiance was calculated at approximately 26 W m⁻². When compared to the conservative photochemical MPE limit for 600 nm (the closest applicable limit in the standard), the EMMD exposure is 38 times lower.
• Cumulative Exposure: Accounting for the device's regimen (two 3-minute sessions daily, 5 days a week) and biological repair mechanisms, the safety margin remains substantial. For a 7 mm pupil, the margin is approximately 3-fold; for a more realistic 4 mm pupil, the margin increases to approximately 8-fold.
• Human Data Correlation: Comparison with the Robertson et al. study showed that volunteers exposed to 5.1 mW for 15 minutes (equivalent to 1 mW for 75 minutes via reciprocity) exhibited no structural or functional retinal injury. The EMMD's daily exposure (6 minutes at 1 mW) represents a significantly lower energy load, with a calculated safety margin of roughly 2.8-fold (7 mm pupil) to 8.5-fold (4 mm pupil) after accounting for multi-day additivity.

Significance and Claims
The paper concludes that the exposure parameters of the EMMD remain well below conservative retinal injury thresholds under prescribed use conditions. The authors assert that the integration of experimental measurements, computational modeling, and human volunteer data demonstrates substantial safety margins.

The study emphasizes that while the device falls into the Class 3R category based on general laser safety standards, these standards were not designed for therapeutic use. Therefore, the risk-benefit analysis for myopia treatment is paramount. The authors claim that the EMMD is safe for clinical use when operated according to the manufacturer's software controls, which limit exposure duration and frequency. However, they modestly note that individuals with specific photosensitivities (e.g., due to medication) may require precautions. The paper does not claim to provide new clinical efficacy data but rather provides the necessary biophysical safety validation to support the continued clinical application of this therapy.